Clinical Trials Logo

Clinical Trial Summary

Hyaline membrane disease, now commonly called respiratory distress syndrome (RDS), and feeding intolerance, which can lead to necrotizing enterocolitis (NEC), are two key morbidities found in premature neonates which resulted in high mortality rate in Indonesia. Cochrane meta-analysis proved that antenatal steroid therapy can reduce the morbidity and mortality rate of premature neonates. But there is still different outcomes and severity of disease in preterm newborn receiving the same dose of antenatal steroid therapy. This raises questions whether there are other factors influencing the development and maturity of lung and gut in preterm newborn, aside from steroid therapy. Vitamin A, D and zinc are already known for their function in fetal lung and gut development. To our best of knowledge, no study has evaluated the effect of these vitamins levels on HMD and feeding intolerance in premature neonates. Therefore, the aim of this study want to evaluate the effect of antenatal steroid therapy versus co-administered β-carotene, vitamin D3, zinc and antenatal steroid therapy on the presence and severity of HMD and feeding intolerance in premature neonates.


Clinical Trial Description

This study is a randomized controlled trial and held in Cipto Mangunkusumo Hospital.

Pregnant women 28-34 weeks of gestational age, who fulfill the inclusion criteria, divide into two groups. Subjects from both groups receive the hospital protocol of preterm birth, 4 doses of 6 mg of dexamethasone, intravenous 12 hours apart to support lung maturation. Subjects in intervention group receive oral single-dose beta-carotene 25,000 IU, oral single-dose vitamin D3 50,000 IU and oral zinc 50 mg/day for 3 days. The maternal dan cord blood sample are obtained for zinc, vitamin A and 25(OH)D levels before and after intervention. After the premature neonates was born, observation will be done for maximum period of 4 weeks. The presence and severity of HMD and feeding intolerance or NEC will be recorded. Neonates showing any signs of HMD and/or abdominal distension will need to undergo additional chest/abdominal x-ray procedures. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03366584
Study type Interventional
Source Indonesia University
Contact Yuyun Lisnawati
Email yulisna.er@gmail.com
Status Recruiting
Phase Phase 4
Start date January 2017
Completion date June 2019

See also
  Status Clinical Trial Phase
Completed NCT03926390 - Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial N/A
Completed NCT03111329 - Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding? N/A
Recruiting NCT05619055 - The Intestinal Dysbacteriosis in the Pathogenesis of Necrotizing Enterocolitis
Recruiting NCT03549507 - CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis Phase 3
Completed NCT04977817 - Probiotics/TPN in the NICU
Completed NCT03136172 - Monitoring of Systemic or Organ Perfusion for Preterm Infants
Completed NCT04719546 - Risk Factors of Necrotizing Enterocolitis in Premature Newborns
Recruiting NCT04083638 - The Relationship Between Erythrocyte Transfusion and Nutrition and Necrotizing Enterocolitis in Preterm Infants
Not yet recruiting NCT05710575 - Role of Probiotic Use in Outcomes of Premature Birth N/A
Recruiting NCT05121753 - Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Recruiting NCT03997266 - NICU Antibiotics and Outcomes Trial Phase 4